Your browser doesn't support javascript.
loading
Correction to: Real-world multicentre cohort of first-line pembrolizumab alone or in combination with platinum-based chemotherapy in non-small cell lung cancer PD-L1 ≥ 50.
Pons-Tostivint, E; Hulo, P; Guardiolle, V; Bodot, L; Rabeau, A; Porte, M; Hiret, S; Demontrond, P; Curcio, H; Boudoussier, A; Veillon, R; Mayenga, M; Dumenil, C; Chatellier, T; Gourraud, P A; Mazieres, J; Bennouna, J.
Afiliación
  • Pons-Tostivint E; Centre Hospitalier Universitaire Nantes, Medical Oncology, Nantes University, 44000, Nantes, France. elvire.pons@chu-nantes.fr.
  • Hulo P; Medical Oncology Unit, Clinique Mutualiste de L'Estuaire, Saint-Nazaire, France.
  • Guardiolle V; Centre Hospitalier Universitaire Nantes, Institute of Health and Medical Research, Santé Publique, Clinique Des Données, Inserm CIC 1413, Centre Hospitalier Universitaire de Nantes, Nantes University, 44000, Nantes, France.
  • Bodot L; Thoracic Oncology Department, Hôpital Larrey, CHU Toulouse, 31000, Toulouse, France.
  • Rabeau A; Thoracic Oncology Department, Hôpital Larrey, CHU Toulouse, 31000, Toulouse, France.
  • Porte M; Department of Medical Oncology, Comprehensive Cancer Center, Institut de Cancérologie de L'Ouest, Saint-Herblain, France.
  • Hiret S; Department of Medical Oncology, Comprehensive Cancer Center, Institut de Cancérologie de L'Ouest, Saint-Herblain, France.
  • Demontrond P; Department of Pneumology, Centre François Baclesse, Caen, France.
  • Curcio H; Department of Pneumology, Centre François Baclesse, Caen, France.
  • Boudoussier A; Department of Pneumology, University Hospital of Bordeaux, Pessac, France.
  • Veillon R; Department of Pneumology, University Hospital of Bordeaux, Pessac, France.
  • Mayenga M; Department of Medical Oncology, Hospital Foch, Suresnes, France.
  • Dumenil C; Department of Respiratory Diseases and Thoracic Oncology, APHP-Hopital Ambroise Pare, 92100, Boulogne-Billancourt, France.
  • Chatellier T; Medical Oncology Unit, Clinique Mutualiste de L'Estuaire, Saint-Nazaire, France.
  • Gourraud PA; Centre Hospitalier Universitaire Nantes, Institute of Health and Medical Research, Santé Publique, Clinique Des Données, Inserm CIC 1413, Centre Hospitalier Universitaire de Nantes, Nantes University, 44000, Nantes, France.
  • Mazieres J; Thoracic Oncology Department, Hôpital Larrey, CHU Toulouse, 31000, Toulouse, France.
  • Bennouna J; Department of Medical Oncology, Hospital Foch, Suresnes, France.
Cancer Immunol Immunother ; 72(6): 1891-1892, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36847863
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancer Immunol Immunother Asunto de la revista: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Año: 2023 Tipo del documento: Article País de afiliación: Francia